SuperworthEdap TMS FOCL
Medical - Devices, Healthcare
$4.17
+0.48%
- Market cap
- $156.5M
- PE
- n/m
- one or more of the four quarters through 2026-06-30 missing
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- n/m
- one or more of the four quarters through 2026-06-30 missing
- EV/EBIT
- n/m
- not a meaningful number
- Revenue, 12 months
- n/m
- one or more of the four quarters through 2026-06-30 missing
- Net margin
- n/m
- one or more of the four quarters through 2026-06-30 missing
- Free cash flow yield
- n/m
- not a meaningful number
Charts
Financials
| Income statement | Q1 FY25 | Q2 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|
| $14.3M | $9.5M | $17.8M | $13.2M | |
| Cost of revenue | $8.3M | $4.6M | $9.7M | $5.9M |
| Gross profit | $6M | $4.9M | $8.1M | $7.3M |
| R&D | $2.6M | $2.3M | $2.6M | $2.3M |
| SG&A | $9.7M | $9.2M | $12.9M | $13.1M |
| −$6.3M | −$6.6M | −$7.4M | −$8M | |
| Pre-tax income | −$7.3M | −$6.3M | −$8.9M | −$14.4M |
| $144K | $14K | $145K | $8K | |
| Net income | −$7.4M | −$6.4M | −$9.1M | −$14.5M |
| −$0.20 | −$0.17 | −$0.24 | −$0.39 | |
| 37.4M | 37.4M | 37.5M | 37.5M |
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Healthcare nearest Edap TMS' size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| FOCLEdap TMS | $156.5M | n/m | n/a | n/m | n/m | n/m | |
| PDEXPro DEX | $199.3M | 15.1× | 16.6× | 2.6× | +16% | 17.6% | |
| PLXProtalix BioTherapeutics | $205.5M | 11.1× | 34.2× | 2.5× | +30% | 23.5% | |
| NATRNatures Sunshine Products | $213.8M | 12.0× | 20.6× | 0.4× | +7% | 3.7% | |
| ELMDElectromed | $220.6M | 20.1× | 29.0× | 3.0× | +15% | 15.3% | |
| UTMDUtah Medical Products | $236.3M | 22.6× | 20.9× | 6.5× | −7% | 29.0% | |
| KEQUKewaunee Scientific | $94.9M | 11.9× | 13.7× | 0.3× | +5% | 3.0% | |
| ICCCImmucell | $93.1M | 128× | 44.0× | 3.0× | +8% | 2.6% | |
| INFUInfuSystem | $277.6M | 34.0× | 43.5× | 1.9× | +2% | 6.0% | |
| LFVNLifevantage | $73.4M | 14.7× | 19.6× | 0.4× | −20% | 2.8% | |
| VMDViemed Healthcare | $373.3M | 27.2× | 26.1× | 1.2× | +25% | 4.8% | |
| Peer median | $209.6M | 17.6× | 23.5× | 2.2× | +8% | 5.4% |
More on Edap TMS
Each number over time
Its groups
About
- Industry
- Medical - Devices
- Sector
- Healthcare
Valuation data, not investment advice. Prices as of .